Oxytocin Administration in BDD and OCD

计划入组 41 人 · 首次发布于 2016 年 2 月 2 日

BDD With UDCA Therapy After Laparoscopic Cholecystectomy

计划入组 172 人 · 首次发布于 2018 年 7 月 5 日

Perceptual Abnormalities and Their Malleability in BDD

计划入组 146 人 · 首次发布于 2020 年 5 月 4 日

BDD-40001

BDD-10103

BDD-104XX

BDD PHARMA LTD

United Kingdom

RDD Pharma Ltd.

Israel

RDD PHARMA LTD

Israel

BDD Pharma's OralogiK System Advances Timed-Release Drug Delivery for ADHD and Rheumatoid Arthritis

Cingulate Appoints Chief Legal Officer as Company Prepares FDA Filing for Novel ADHD Treatment

Cingulate's Phase 3 Trial Shows Promising Results for Once-Daily ADHD Treatment CTx-1301